BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31338319)

  • 1. The Profile of Immunophenotype and Genotype Aberrations in Subsets of Pediatric T-Cell Acute Lymphoblastic Leukemia.
    Noronha EP; Marques LVC; Andrade FG; Thuler LCS; Terra-Granado E; Pombo-de-Oliveira MS;
    Front Oncol; 2019; 9():316. PubMed ID: 31338319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with
    Noronha EP; Marques LVC; Andrade FG; Sardou-Cezar I; Dos Santos-Bueno FV; Zampier CDP; Terra-Granado E; Pombo-de-Oliveira MS
    Cancer Manag Res; 2019; 11():3933-3943. PubMed ID: 31118806
    [No Abstract]   [Full Text] [Related]  

  • 3. CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia.
    Marques LVC; Noronha EP; Andrade FG; Dos Santos-Bueno FV; Mansur MB; Terra-Granado E; Pombo-de-Oliveira MS
    Front Oncol; 2018; 8():488. PubMed ID: 30430079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of NOTCH1/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial.
    Jenkinson S; Koo K; Mansour MR; Goulden N; Vora A; Mitchell C; Wade R; Richards S; Hancock J; Moorman AV; Linch DC; Gale RE
    Leukemia; 2013 Jan; 27(1):41-7. PubMed ID: 22814294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII/ECOG E2993 protocol.
    Mansour MR; Sulis ML; Duke V; Foroni L; Jenkinson S; Koo K; Allen CG; Gale RE; Buck G; Richards S; Paietta E; Rowe JM; Tallman MS; Goldstone AH; Ferrando AA; Linch DC
    J Clin Oncol; 2009 Sep; 27(26):4352-6. PubMed ID: 19635999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
    Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
    Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
    Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of key copy number alterations in T cell acute lymphoblastic leukemia.
    Kumari S; Ali MS; Singh J; Arora M; Verma D; Pandey AK; Benjamin M; Bakhshi S; Palanichamy JK; Sharma A; Singh I; Tanwar P; Singh AR; Pushpam D; Qamar I; Chopra A
    Hematol Oncol; 2022 Oct; 40(4):577-587. PubMed ID: 35644022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy Number Alterations in CDKN2A/2B and MTAP Genes Are Associated With Low MEF2C Expression in T-cell Acute Lymphoblastic Leukemia.
    Kumari S; Singh J; Arora M; Ali MS; Pandey AK; Benjamin M; Palanichamy JK; Bakhshi S; Qamar I; Chopra A
    Cureus; 2022 Dec; 14(12):e32151. PubMed ID: 36601176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTCH1 and/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols.
    Zuurbier L; Homminga I; Calvert V; te Winkel ML; Buijs-Gladdines JG; Kooi C; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Petricoin EF; Pieters R; Meijerink JP
    Leukemia; 2010 Dec; 24(12):2014-22. PubMed ID: 20861909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Identification of Key Copy Number Alterations in B- and T-Cell Acute Lymphoblastic Leukemia by Digital Multiplex Ligation-Dependent Probe Amplification.
    Thakral D; Kaur G; Gupta R; Benard-Slagter A; Savola S; Kumar I; Anand R; Rani L; Verma P; Joshi S; Kumar L; Sharma A; Bakhshi S; Seth R; Singh V
    Front Oncol; 2019; 9():871. PubMed ID: 31572674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma.
    Callens C; Baleydier F; Lengline E; Ben Abdelali R; Petit A; Villarese P; Cieslak A; Minard-Colin V; Rullier A; Moreau A; Baruchel A; Schmitt C; Asnafi V; Bertrand Y; Macintyre E
    J Clin Oncol; 2012 Jun; 30(16):1966-73. PubMed ID: 22547598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of
    Yuan Y; Li J; Xue TL; Hu HR; Lin W; Liu SG; Zhang RD; Zheng HY; Gao C
    Leuk Lymphoma; 2022 Jul; 63(7):1624-1633. PubMed ID: 35129045
    [No Abstract]   [Full Text] [Related]  

  • 14. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
    Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.
    Neumann M; Heesch S; Gökbuget N; Schwartz S; Schlee C; Benlasfer O; Farhadi-Sartangi N; Thibaut J; Burmeister T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
    Blood Cancer J; 2012 Jan; 2(1):e55. PubMed ID: 22829239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinico-Hematological Profile and Copy Number Abnormalities in a Cohort of
    Patra N; Singh M; Sharma P; Trehan A; Naseem S; Bansal D; Bhatia P
    Indian J Hematol Blood Transfus; 2021 Oct; 37(4):555-562. PubMed ID: 34744339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study.
    Asnafi V; Buzyn A; Le Noir S; Baleydier F; Simon A; Beldjord K; Reman O; Witz F; Fagot T; Tavernier E; Turlure P; Leguay T; Huguet F; Vernant JP; Daniel F; Béné MC; Ifrah N; Thomas X; Dombret H; Macintyre E
    Blood; 2009 Apr; 113(17):3918-24. PubMed ID: 19109228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
    Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL.
    Van Vlierberghe P; Homminga I; Zuurbier L; Gladdines-Buijs J; van Wering ER; Horstmann M; Beverloo HB; Pieters R; Meijerink JP
    Leukemia; 2008 Apr; 22(4):762-70. PubMed ID: 18185524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic mutational profiling analysis of T cell acute lymphoblastic leukemia reveal mutant FBXW7 as a prognostic indicator for inferior survival.
    Yuan L; Lu L; Yang Y; Sun H; Chen X; Huang Y; Wang X; Zou L; Bao L
    Ann Hematol; 2015 Nov; 94(11):1817-28. PubMed ID: 26341754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.